JASON SAUL: Open Payments
NPI 1568990828 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,370 in 117 payments from 16 companies in 2025. Trend: 2023 $1,837 · 2024 $2,395 · 2025 $2,370
Food & beverage: $2,262Education: $108
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $309 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $296 |
| ABBVIE INC. | 16 | $278 |
| Janssen Biotech, Inc. | 10 | $274 |
| LEO Pharma Inc. | 9 | $198 |
| Novartis Pharmaceuticals Corporation | 8 | $180 |
| Incyte Corporation | 9 | $177 |
| PFIZER INC. | 6 | $130 |
| Organon LLC | 7 | $128 |
| Lilly USA, LLC | 6 | $106 |
Products named: Bimzelx, TREMFYA, OPZELURA, SKYRIZI, Winlevi, ADBRY, CIBINQO, COSENTYX.
Industry payments across DE — which companies pay providers there.
